106 related articles for article (PubMed ID: 10604414)
1. p53 expression in locally advanced pharyngeal squamous cell carcinoma.
Lassaletta L; Brandáriz JA; Benito A; de la Cruz J; Gómez C; Ballestín C; Hitt R; Colomer R; Alvarez-Vicent JJ
Arch Otolaryngol Head Neck Surg; 1999 Dec; 125(12):1356-9. PubMed ID: 10604414
[TBL] [Abstract][Full Text] [Related]
2. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G
Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
[TBL] [Abstract][Full Text] [Related]
4. Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy.
Muro K; Ohtsu A; Boku N; Chin K; Oda Y; Fujii T; Hosokawa K; Yoshida S; Hasebe T
Jpn J Clin Oncol; 1996 Apr; 26(2):65-9. PubMed ID: 8609696
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy.
Necchi A; Lo Vullo S; Nicolai N; Raggi D; Giannatempo P; Colecchia M; Catanzaro M; Torelli T; Piva L; Biasoni D; Stagni S; Mariani L; Salvioni R
Clin Genitourin Cancer; 2016 Dec; 14(6):518-523. PubMed ID: 27050716
[TBL] [Abstract][Full Text] [Related]
7. Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma.
Koh Y; Kim TM; Jeon YK; Kwon TK; Hah JH; Lee SH; Kim DW; Wu HG; Rhee CS; Sung MW; Kim CW; Kim KH; Heo DS
Ann Oncol; 2009 Aug; 20(8):1414-9. PubMed ID: 19468031
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.
Hsu CH; Chen CL; Hong RL; Chen KL; Lin JF; Cheng AL
Oncology; 2002; 62(4):305-12. PubMed ID: 12138237
[TBL] [Abstract][Full Text] [Related]
10. p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck.
Temam S; Flahault A; Périé S; Monceaux G; Coulet F; Callard P; Bernaudin JF; St Guily JL; Fouret P
J Clin Oncol; 2000 Jan; 18(2):385-94. PubMed ID: 10637254
[TBL] [Abstract][Full Text] [Related]
11. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
12. Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.
Su YY; Chien CY; Luo SD; Huang TL; Lin WC; Fang FM; Chiu TJ; Chen YH; Lai CC; Hsu CM; Li SH
World J Surg Oncol; 2016 Mar; 14():86. PubMed ID: 27001663
[TBL] [Abstract][Full Text] [Related]
13. beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial.
Cullen KJ; Schumaker L; Nikitakis N; Goloubeva O; Tan M; Sarlis NJ; Haddad RI; Posner MR
J Clin Oncol; 2009 Dec; 27(36):6222-8. PubMed ID: 19917838
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of p53 protein as a prognostic factor for oral cancer surgery.
Cutilli T; Leocata P; Dolo V; Altobelli E
Br J Oral Maxillofac Surg; 2013 Dec; 51(8):922-7. PubMed ID: 23791033
[TBL] [Abstract][Full Text] [Related]
15. p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation.
Cutilli T; Papola F; Di Emidio P; Corbacelli A
J Chemother; 1998 Oct; 10(5):411-7. PubMed ID: 9822361
[TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.
Bradford CR; Zhu S; Wolf GT; Poore J; Fisher SG; Beals T; McClatchey KD; Carey TE
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):408-12. PubMed ID: 7567013
[TBL] [Abstract][Full Text] [Related]
19. [p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment].
Cutilli T; Papola F; Di Emidio P; Leocata P; Corbacelli A
Minerva Stomatol; 1998; 47(1-2):1-9. PubMed ID: 9578641
[TBL] [Abstract][Full Text] [Related]
20. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
Yamasaki M; Miyata H; Fujiwara Y; Takiguchi S; Nakajima K; Nishida T; Yasuda T; Matsuyama J; Mori M; Doki Y
Ann Surg Oncol; 2010 Feb; 17(2):634-42. PubMed ID: 19941080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
